JP2024520790A5 - - Google Patents

Info

Publication number
JP2024520790A5
JP2024520790A5 JP2023575724A JP2023575724A JP2024520790A5 JP 2024520790 A5 JP2024520790 A5 JP 2024520790A5 JP 2023575724 A JP2023575724 A JP 2023575724A JP 2023575724 A JP2023575724 A JP 2023575724A JP 2024520790 A5 JP2024520790 A5 JP 2024520790A5
Authority
JP
Japan
Prior art keywords
kallikrein
sequence
cells
nucleotide sequence
gpi
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2023575724A
Other languages
English (en)
Japanese (ja)
Other versions
JP2024520790A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/IB2022/055355 external-priority patent/WO2022259190A1/en
Publication of JP2024520790A publication Critical patent/JP2024520790A/ja
Publication of JP2024520790A5 publication Critical patent/JP2024520790A5/ja
Pending legal-status Critical Current

Links

JP2023575724A 2021-06-10 2022-06-08 Ｋｌｋ２－ｇｐｉ融合タンパク質をコードする核酸、組換え細胞、及びその使用 Pending JP2024520790A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202163209019P 2021-06-10 2021-06-10
US63/209,019 2021-06-10
PCT/IB2022/055355 WO2022259190A1 (en) 2021-06-10 2022-06-08 Nucleic acid coding for klk2-gpi fusion protein, recombinant cells, and uses thereof

Publications (2)

Publication Number Publication Date
JP2024520790A JP2024520790A (ja) 2024-05-24
JP2024520790A5 true JP2024520790A5 (enExample) 2025-06-11

Family

ID=82358484

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023575724A Pending JP2024520790A (ja) 2021-06-10 2022-06-08 Ｋｌｋ２－ｇｐｉ融合タンパク質をコードする核酸、組換え細胞、及びその使用

Country Status (11)

Country Link
US (1) US20220403397A1 (enExample)
EP (1) EP4352217A1 (enExample)
JP (1) JP2024520790A (enExample)
KR (1) KR20240021211A (enExample)
CN (1) CN117480253A (enExample)
AU (1) AU2022291273A1 (enExample)
BR (1) BR112023025616A2 (enExample)
CA (1) CA3222756A1 (enExample)
IL (1) IL309179A (enExample)
MX (1) MX2023014793A (enExample)
WO (1) WO2022259190A1 (enExample)

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4873191A (en) 1981-06-12 1989-10-10 Ohio University Genetic transformation of zygotes
US5175384A (en) 1988-12-05 1992-12-29 Genpharm International Transgenic mice depleted in mature t-cells and methods for making transgenic mice
GB8901778D0 (en) 1989-01-27 1989-03-15 Univ Court Of The University O Manipulatory technique
US5585362A (en) 1989-08-22 1996-12-17 The Regents Of The University Of Michigan Adenovirus vectors for gene therapy
DE69233013T2 (de) 1991-08-20 2004-03-04 The Government Of The United States Of America As Represented By The Secretary Of National Institute Of Health, Office Of Technology Transfer Adenovirus vermittelter gentransfer in den gastrointestinaltrakt
FR2688514A1 (fr) 1992-03-16 1993-09-17 Centre Nat Rech Scient Adenovirus recombinants defectifs exprimant des cytokines et medicaments antitumoraux les contenant.
US5602299A (en) 1992-09-23 1997-02-11 Mount Sinai School Of Medicine Of The City University Of New York Transgenic animal models for neurodegenerative disease
EP1024198A3 (en) 1992-12-03 2002-05-29 Genzyme Corporation Pseudo-adenoviral vectors for the gene therapy of haemophiliae
EP0705344B8 (en) 1993-06-24 2006-05-10 Advec Inc. Adenovirus vectors for gene therapy
US5516639A (en) * 1993-07-22 1996-05-14 Mayo Foundation For Medical Education And Research Antibodies specific for human prostate glandular kallkrein
AU687117B2 (en) 1993-10-25 1998-02-19 Canji, Inc. Recombinant adenoviral vector and methods of use
JPH07132033A (ja) 1993-11-12 1995-05-23 Hoechst Japan Ltd アルツハイマー病モデルトランスジェニック動物
US6113917A (en) * 1995-04-25 2000-09-05 Rmf Dictagene S.A. Modified polypeptides for enhanced immunogenicity
US6066778A (en) 1996-11-06 2000-05-23 The Regents Of The University Of Michigan Transgenic mice expressing APC resistant factor V
DK1716233T3 (da) * 2004-01-30 2009-10-26 Maxygen Holdings Ltd Reguleret stopkodongennemlæsning
AU2005295421A1 (en) * 2004-10-18 2006-04-27 Zymogenetics, Inc. Soluble Zcytor21, anti-Zcytor21 antibodies and binding partners and methods of using in inflammation
EP2315846A4 (en) * 2008-08-05 2011-11-30 Univ Rochester PSA AND KLK2 AS THERAPEUTIC TARGET MOLECULES AND PSA AND KLK2-INHIBITABLE MOLECULES
WO2012068317A2 (en) * 2010-11-16 2012-05-24 Excelimmune, Inc. Methods for producing recombinant proteins
JP7235436B2 (ja) * 2014-11-10 2023-03-08 ザ ボード オブ トラスティーズ オブ ザ レランド スタンフォード ジュニア ユニバーシティー 細胞の表面上にポリペプチドを発現させるための組成物および方法
AU2020322221A1 (en) * 2019-07-26 2022-03-24 Janssen Biotech, Inc. Anti-hK2 chimeric antigen receptor (CAR)

Similar Documents

Publication Publication Date Title
RU2577971C2 (ru) Система для увеличения экспрессии генов и вектор, содержащий указанную систему
ES2625316T3 (es) Neuquinasa, una proteína corriente abajo de neuregulina
JP5264518B2 (ja) マルチマータンパク質およびマルチマータンパク質を作製および使用する方法
ES2271004T3 (es) Uso de taci como agente antitumoral.
JP4500541B2 (ja) ウイルスコートタンパク質／受容体キメラおよび使用方法
JP7770368B2 (ja) ヒト化ａｓｇｒ１座位を含む非ヒト動物
US20200085871A1 (en) Methods of using cytotoxic t cells for treatment of autoimmune diseases
US8993742B2 (en) Tubulo-vesicular structure localization signals
AU1162100A (en) Method for producing antibodies acting against a polypeptide that only recognises the coding nucleic acid
CN110799530A (zh) Hla-g转录物和同种型及它们的用途
JPWO2006035741A1 (ja) Ｅｓ細胞特異的発現遺伝子及びその利用
Drewlo et al. C-Terminal truncations of syncytin-1 (ERVWE1 envelope) that increase its fusogenicity.
JP2024520790A5 (enExample)
US8318662B2 (en) Protein increasing cell infectivity of herpes simplex virus and use thereof
FI3687287T3 (fi) Humanisoitua c1q-kompleksia ilmentävät jyrsijät
ES2284532T3 (es) Quimeras de proteina de envuelta viral/receptor y metodos de uso.
US20220403397A1 (en) Nucleic acid constructs encoding kallikrein-2 fusion protein and vectors, preparations of cells, and methods of use thereof
US20260053122A1 (en) Transgenic animals expressing chimeric c-kit protein
US20250352618A1 (en) Methods of treating bronchopulmonary dysplasia
JP2008283882A (ja) タグ抗体発現トランスジェニック非ヒト動物およびタグ付与型アデノウイルスベクターによる遺伝子導入方法
JP2001519180A (ja) ラミニン及びそれらの利用
KR101389088B1 (ko) 염기서열 최적화된 나트륨-요오드 수송체 유전자 및 그 용도
NZ783284B2 (en) Modified adenoviruses
WO2005040380A1 (ja) げっ歯類動物の免疫応答調節蛋白質
Chen et al. Expression profile of mouse BWF1, a protein with a BEACH domain, WD40 domain and FYVE domain